450 related articles for article (PubMed ID: 21705878)
21. Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study.
Sharma N; Falera R; Arora T; Agarwal T; Bandivadekar P; Vajpayee RB
Br J Ophthalmol; 2016 Mar; 100(3):323-7. PubMed ID: 26271267
[TBL] [Abstract][Full Text] [Related]
22. Combined penetrating keratoplasty and vitreoretinal surgery with silicone oil: a 1-year follow-up.
Roters S; Hamzei P; Szurman P; Hermes S; Thumann G; Bartz-Schmidt KU; Kirchhof B
Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):24-33. PubMed ID: 12545289
[TBL] [Abstract][Full Text] [Related]
23. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
Verdejo-Gómez L; Peláez N; Gris O; Güell JL
Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
[TBL] [Abstract][Full Text] [Related]
24. In vivo laser scanning confocal microscopy of the cornea in patients with silicone oil tamponade after vitreoretinal surgery.
Le Q; Wang X; Lv J; Sun X; Xu J
Cornea; 2012 Aug; 31(8):876-82. PubMed ID: 22511025
[TBL] [Abstract][Full Text] [Related]
25. Pediatric keratoprosthesis.
Aquavella JV; Gearinger MD; Akpek EK; McCormick GJ
Ophthalmology; 2007 May; 114(5):989-94. PubMed ID: 17467531
[TBL] [Abstract][Full Text] [Related]
26. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
[TBL] [Abstract][Full Text] [Related]
27. Boston type 1 keratoprosthesis for failed keratoplasty.
Hager JL; Phillips DL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
Int Ophthalmol; 2016 Feb; 36(1):73-78. PubMed ID: 25975459
[TBL] [Abstract][Full Text] [Related]
28. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
Shah KJ; Cheung AY; Holland EJ
Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
[TBL] [Abstract][Full Text] [Related]
29. The Boston Keratoprosthesis in severe ocular trauma.
Harissi-Dagher M; Dohlman CH
Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
[TBL] [Abstract][Full Text] [Related]
30. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
[TBL] [Abstract][Full Text] [Related]
31. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
[TBL] [Abstract][Full Text] [Related]
32. Results of penetrating keratoplasty in bullous silicone oil keratopathy.
Karel I; Kalvodová B; Kuthan P
Graefes Arch Clin Exp Ophthalmol; 1998 Apr; 236(4):255-8. PubMed ID: 9561356
[TBL] [Abstract][Full Text] [Related]
33. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
Palioura S; Kim B; Dohlman CH; Chodosh J
Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
[TBL] [Abstract][Full Text] [Related]
34. [Histopathology of 8 corneal buttons after penetrating keratoplasty in silicone oil-associated keratopathy].
Sekundo W; Hesse L; Schmidt J; Kroll P
Klin Monbl Augenheilkd; 2001 Jun; 218(6):424-8. PubMed ID: 11488008
[TBL] [Abstract][Full Text] [Related]
35. AlphaCor keratoprosthesis: a novel approach to minimize the risks of long-term postoperative complications.
Ngakeng V; Hauck MJ; Price MO; Price FW
Cornea; 2008 Sep; 27(8):905-10. PubMed ID: 18724152
[TBL] [Abstract][Full Text] [Related]
36. Boston Type 1 Keratoprosthesis for Gelatinous Drop-Like Corneal Dystrophy.
Lekhanont K; Jongkhajornpong P; Chuephanich P; Inatomi T; Kinoshita S
Optom Vis Sci; 2016 Jun; 93(6):640-6. PubMed ID: 26990741
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
Aravena C; Bozkurt TK; Yu F; Aldave AJ
Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
[TBL] [Abstract][Full Text] [Related]
38. Permanent keratoprosthesis combined with pars plana vitrectomy and silicone oil injection for visual rehabilitation of chronic hypotony and corneal opacity.
Utine CA; Gehlbach PL; Zimmer-Galler I; Akpek EK
Cornea; 2010 Dec; 29(12):1401-5. PubMed ID: 20847680
[TBL] [Abstract][Full Text] [Related]
39. Boston type 1 keratoprosthesis: the New York Eye and Ear experience.
Patel AP; Wu EI; Ritterband DC; Seedor JA
Eye (Lond); 2012 Mar; 26(3):418-25. PubMed ID: 22173079
[TBL] [Abstract][Full Text] [Related]
40. Boston keratoprosthesis type I in the elderly.
Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
